Section G. Comparing Means between More than Two Independent Populations

Similar documents
Comparing Means among Two (or More) Independent Populations. John McGready Johns Hopkins University

Confounding and Effect Modification. John McGready Johns Hopkins University

Section B. Variability in the Normal Distribution: Calculating Normal Scores

Section F. Measures of Association: Risk Difference, Relative Risk, and the Odds Ratio

Comparing Proportions between Two Independent Populations. John McGready Johns Hopkins University

Section C. Sample Size Determination for Comparing Two Proportions

Section D. Another Non-Randomized Study Design: The Case-Control Design

Comparing Proportions between Two Independent Populations. John McGready Johns Hopkins University

Describing Data: Part I. John McGready Johns Hopkins University

One way Analysis of Variance (ANOVA)

[Source: Freedman, Pisani, Purves (1998) Statistics, 3rd ed., Ch 2.]

Statistics for Psychosocial Research Lecturer: William Eaton

Proposal Writing. Lynda Burton, ScD Johns Hopkins University

Health Issues for Aging Populations

The Impact of Pandemic Influenza on Public Health

Evaluation and Assessment of Health Policy. Gerard F. Anderson, PhD Johns Hopkins University

Experimental design. Basic principles

Study Designs. Lecture 3. Kevin Frick

Changing People s Behavior. Larry Wissow Professor Health, Behavior and Society Johns Hopkins School of Public Health

Section H. Case Study: Risk Assessment Issues Associated with Chloroform

Section B. Self-Regulation, Attention, and Problem Solving

Alcohol. Gordon Smith, MD (MB, ChB Otago), MPH Professor University of Maryland National Study Center for Trauma and EMS

Proteins and Amino Acids. Benjamin Caballero, MD, PhD Johns Hopkins University

Master Class: Fundamentals of Lung Cancer

How to Choose the Wrong Model. Scott L. Zeger Department of Biostatistics Johns Hopkins Bloomberg School

Chapter 3. Pulmonary Function Study Assessments. Mosby items and derived items 2011, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.

Justice in Research Ethics: International Issues. Nancy E. Kass, ScD Johns Hopkins University

Epidemiologic Methods for Evaluating Screening Programs. Rosa M. Crum, MD, MHS Johns Hopkins University

Severe Mental Disorders. Etheldreda Nakimuli-Mpungu, MMed (Psych), MBChB Johns Hopkins University

Section D. Genes whose Mutation can lead to Initiation

STD Epidemiology. Jonathan Zenilman, MD Johns Hopkins University

Epidemiology of Diarrheal Diseases. Robert Black, MD, MPH Johns Hopkins University

En & IH Engineering Aspects of Public Health Crises. Quiz 1

Lecture 3: Digestion and Dieting Physiology

Measure #404: Anesthesiology Smoking Abstinence National Quality Strategy Domain: Effective Clinical Care

Critical Analysis of Popular Diets and Supplements

Introduction, Nosology, and History. William W. Eaton, PhD Johns Hopkins University

Costing in Vaccine Planning and Programming

The Nutrition Transition

Section C. Biomarkers of Early Biological Effect and Altered Structure and Function

Epidemiology of Mood Disorders II: Analytic Epidemiology and the Search for Etiologic Clues. William W. Eaton, PhD Johns Hopkins University

Diseases caused by Smoking

Statistics Assignment 11 - Solutions

Quality ID #404: Anesthesiology Smoking Abstinence National Quality Strategy Domain: Effective Clinical Care

TB Epidemiology. Richard E. Chaisson, MD Johns Hopkins University Center for Tuberculosis Research

The Impact of Pandemic Influenza on Public Health

DOES SMOKING MARIJUANA INCREASE THE RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE?

Economic Evaluation. Introduction to Economic Evaluation

Statins in lung disease

Measurement of Psychopathology in Populations. William W. Eaton, PhD Johns Hopkins University

Quality ID#164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clincial Care

Nicotine Management and Smoke Free

National COPD Audit Programme

STATISTICS IN CLINICAL AND TRANSLATIONAL RESEARCH

Section 37 1 The Circulatory System (pages )

Section 37 1 The Circulatory System (pages )

Supplementary Online Content

New Drug Targets. Sean T. Prigge, PhD

Comparison of pulmonary function between smokers and non-smokers among out patients of Raja Muthaiah Medical College and Hospital, Cuddalore District

Monitoring and Evaluation IN ACTION! Duff Gillespie

3.0 METHODS. 3.1 Participants

Creative Commons Attribution-NonCommercial-Share Alike License

Measure #402: Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Community / Population Health

Measuring association in contingency tables

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Our Smokefree Trust. Patient Information Leaflet. Easy Read

Comparison of Frequency of FEV1 in Asymptomatic Smoker and Nonsmoker Doctors


Post Procedural Care

Health Effects of Passive Smoking

Meanings of medications, metonymy. Peter Winch. Health Behavior Change at the Individual, Household and Community Levels

Raising tobacco taxes in Bangladesh in FY : An opportunity for development

NHS Leicester City/Leicester City Council Directorate of Public Health

University of Toronto Governing Council

Salt Iodization in Haiti: Challenges to Improving Salt Production Quality and Recommendations for Pursuing Iodization

Pulmonary Function Testing The Basics of Interpretation

COPD: Genomic Biomarker Status and Challenge Scoring

STI Prevention: Housekeeping and How We Use Public Health. M. Terry Hogan, MPH Johns Hopkins University

Chronic obstructive pulmonary disease in over 16s: diagnosis and management

Social Capital. Ginny Tedrow. Health Behavior Change at the Individual, Household and Community Levels

CHARACTERIZING PASSIVE EXPOSURE TO TOBACCO SMOKE

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

Ozone and Health: Clinical Studies. Mark W. Frampton MD University of Rochester Medical Center Rochester, NY

Breast Cancer Basics. Clinical Oncology for Public Health Professionals. Ben Ho Park, MD, PhD

What do pulmonary function tests tell you?

Defining Mental Disorders. Judy Bass, MPH, PhD Johns Hopkins University

CLINICAL BIOSTATISTICS

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Ivax Pharmaceuticals UK Sponsor Submission to the National Institute for Health and Clinical Excellence

L. B. Redbridge ANTI-SMOKING POLICY. For FOSTER CARERS, SHARED CARERS, RESPITE CARERS, KINSHIP CARERS AND SUPPPORTED LODGINGS PROVIDERS

X. Xu*, S.T. Weiss**, B. Rijcken +, J.P. Schouten +

Prevalence of past year substance use in British Columbia and other provinces of Canada from 2008 to 2012

LONGITUDINAL STUDY OF LUNG FUNCTION DEVELOPMENT IN A COHORT OF INDIAN MEDICAL STUDENTS: INTERACTION OF RESPIRATORY ALLERGY AND SMOKING

Using subjective and objective measures to estimate respiratory health in a population of working older Kentucky farmers, Part 2.

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

DIAGNOSTIC ACCREDITATION PROGRAM. Spirometry Quality Control Plan

Quality ID #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care

ANOVA. Thomas Elliott. January 29, 2013

Spirometry. Obstruction. By Helen Grim M.S. RRT. loop will have concave appearance. Flows decreased consistent with degree of obstruction.

Transcription:

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this site. Copyright 2009, The Johns Hopkins University and John McGready. All rights reserved. Use of these materials permitted only in accordance with license rights granted. Materials provided AS IS ; no representations or warranties provided. User assumes all responsibility for use, and all liability related thereto, and must independently review all materials for accuracy and efficacy. May contain materials owned by others. User is responsible for obtaining permissions for use from third parties as needed.

Section G Comparing Means between More than Two Independent Populations

Motivating Example Suppose you are interested in the relationship between smoking and mid-expiratory flow (FEF), a measure of pulmonary health Suppose you recruit study subjects and classify them into one of six smoking categories Nonsmokers (NS) Passive smokers (PS) Non-inhaling smokers (NI) Light smokers (LS) Moderate smokers (MS) Heavy smokers (HS) 3

Motivating Example You are interested in whether differences exist in mean FEF amongst the six groups Main outcome variable is mid-expiratory flow (FEF) in liters per second 4

Motivating Example One strategy is to perform lots of two-sample t-tests (for each possible two-group comparison) In this example, there would be 15 comparisons you would need to do! NS to PS, NS to NI, and so on... 5

Motivating Example It would be nice to have one catch-all test Something which would tell you whether there were any differences amongst the six groups If so, you could then do group to group comparisons to look for specific group differences 6

Extension of the Two-Sample t-test Analysis of variance (One-Way ANOVA) The t-test compares means in two populations ANOVA compares means amongst more than two populations with one test The p-value from ANOVA helps answer the question Are there any differences in the means among the populations? 7

Extension of the Two-Sample t-test General idea behind ANOVA, comparing means for k-groups (k > 2): H o : µ 1 = µ 2 =... µ k H A : At least one mean different 8

Example Smoking and FEF (Forced Mid-Expiratory Flow Rate)* A sample of over 3,000 persons was classified into one of six smoking categorizations based on responses to smoking related questions Source: * White, J.R., Froeb, H.F. (1980). Small-airways dysfunction in non-smokers chronically exposed to tobacco smoke, New England Journal of Medicine 302: 13. 9

Example 1 Nonsmokers (NS) Passive smokers (PS) Non-inhaling smokers (NI) Light smokers (LS) Moderate smokers (MS) Heavy smokers (HS) 10

Example 1 Smoking and FEF From each smoking group, a random sample of 200 men was drawn (except for the non-inhalers, as there were only 50 male non-inhalers in the entire sample of 3,000) FEF measurements were taken on each of the subjects 11

Example 1 Table Data summary Group Mean FEF SD FEF (L/s) (L/s) n NS 3.78 0.79 200 PS 3.30 0.77 200 NI 3.32 0.86 50 LS 3.23 0.78 200 MS 2.73 0.81 200 HS 2.59 0.82 200 Based on a one-way analysis of variance, there are statistically significant differences in FEF levels among the six smoking groups (p <.001) 12

What s the Rationale behind Analysis of Variance? The variation in the sample means between groups is compared to the variation within a group If the between group variation is a lot bigger than the within group variation, that suggests there are some differences among the populations 13

Analysis of Variance 14

Summary: Smoking and FEF Statistical methods 200 men were randomly selected from each of five smoking classification groups (non-smoker, passive smokers, light smokers, moderate smokers, and heavy smokers), as well as 50 men classified as non-inhaling smokers for a study designed to analyze the relationship between smoking and respiratory function 15

Summary: Smoking and FEF Statistical Methods Analysis of variance was used to test for any differences in FEF levels amongst the six groups of men Individual group comparisons were performed with a series of two sample t-tests, and 95% confidence intervals were constructed for the mean difference in FEF between each combination of groups Analysis of variance showed statistically significant (p <.001) differences in FEF between the six groups of smokers Non-smokers had the highest mean FEF value, 3.78 L/s, and this was statistically significantly larger than the five other smokingclassification groups 16

Summary: Smoking and FEF Results Analysis of variance showed statistically significant (p <.001) differences in FEF between the six groups of smokers Non-smokers had the highest mean FEF value, 3.78 L/s, and this was statistically significantly larger than the five other smokingclassification groups The mean FEF value for non-smokers was 1.19 L/s higher than the mean FEF for heavy smokers (95% CI 1.03 1.35 L/s), the largest mean difference between any two smoking groups Confidence intervals for all smoking group FEF comparisons are in Table 1 17

Example 2 FEV1 and three medical centers* Data was collected on 63 patients with coronary artery disease at 3 difference medical centers (Johns Hopkins, Ranchos Los Amigos Medical Center, St. Louis University School of Medicine) Purpose of study to investigate effects of carbon monoxide exposure on these patients Prior to analyzing CO effects data, researchers wished to compare the respiratory health of these patients across the three medical centers Source: * Pagano, M., Gauvreau, K. (2000). Principles of biostatistics. Duxbury Press. 18

Example 2 Snippet of data in Stata 19

Boxplots FEV1 values by center 20

Example 2 ANOVA with Stata syntax oneway outcome_var group_var 21

Example 2 ANOVA with Stata syntax oneway outcome_var group_var 22

Example 2 FEV and 3 medical centers 95% CIs for FEV1 by medical center 23